Celox Medical
Global medical-technology company focused on development, clinical evaluation and commercialization of patented haemostatic and advanced wound-care technologies. Offers end-to-end product development from research and manufacturing to regulatory support, clinical evidence generation and distribution for healthcare, emergency and military settings.
Industries
Nr. of Employees
medium (51-250)
Products
Haemostatic granules
Powdered haemostatic agent designed to be applied into wounds to promote rapid clotting.
Haemostatic gauze
Dressing format incorporating haemostatic material for packing wounds and controlling bleeding.
Haemostatic pads and vascular pads
Pad and sponge products intended to apply pressure and haemostatic agent to bleeding sites, including vascular access areas.
Applicator systems for haemostatic granules
Applicator devices to deliver haemostatic granules into wounds safely and accurately.
X-ray visible haemostatic dressing
Dressing designed to be visible on radiography to aid detection and removal if necessary.
Advanced wound care dressings (foam, border, IV)
Range of advanced wound dressings including foam and border formats and specific intravascular-access dressings.
Haemostatic granules
Powdered haemostatic agent designed to be applied into wounds to promote rapid clotting.
Haemostatic gauze
Dressing format incorporating haemostatic material for packing wounds and controlling bleeding.
Haemostatic pads and vascular pads
Pad and sponge products intended to apply pressure and haemostatic agent to bleeding sites, including vascular access areas.
Applicator systems for haemostatic granules
Applicator devices to deliver haemostatic granules into wounds safely and accurately.
X-ray visible haemostatic dressing
Dressing designed to be visible on radiography to aid detection and removal if necessary.
Advanced wound care dressings (foam, border, IV)
Range of advanced wound dressings including foam and border formats and specific intravascular-access dressings.
Services
Material and formulation R&D for haemostatic agents and wound dressings.
Support for clinical studies, retrospective data analyses and publication of clinical evidence.
Regulatory strategy and quality system support for product approvals and compliance.
Advanced manufacturing and private-label production services for wound-care and haemostatic products.
Commercial and marketing support for global distribution partners.
User training resources and an expert contact channel for clinical and technical enquiries.
Material and formulation R&D for haemostatic agents and wound dressings.
Support for clinical studies, retrospective data analyses and publication of clinical evidence.
Regulatory strategy and quality system support for product approvals and compliance.
Advanced manufacturing and private-label production services for wound-care and haemostatic products.
Commercial and marketing support for global distribution partners.
User training resources and an expert contact channel for clinical and technical enquiries.
Expertise Areas
- Haemostatic product development
- Advanced wound care
- Clinical evidence generation
- Regulatory compliance and quality systems
Key Technologies
- Chitosan-based haemostatic materials
- Haemostatic granules
- Haemostatic gauze and pad formats
- Advanced wound dressing materials (foam, border, IV)
News & Updates
Announcement of a carbon neutral offset program for transportation emissions.
Announcement of corporate rebranding from Medtrade Products to CELOX Medical.
Recognition awarded to a company leader.
Company milestone reflecting 25 years of operations.
Award for scale-up entrepreneurship.
Recognition for innovation in product development.
Announcement of a carbon neutral offset program for transportation emissions.
Announcement of corporate rebranding from Medtrade Products to CELOX Medical.
Recognition awarded to a company leader.
Company milestone reflecting 25 years of operations.
Award for scale-up entrepreneurship.
Recognition for innovation in product development.